headache after semaglutide Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain Does semaglutide cause headaches? Why

Nauck, Diabetes, Obesity, & Metabolism , Occurrence of Nausea, Vomiting and Diarrhea Reported as Adverse Events in Clinical Trials Studying Glucagon-like Peptide-1 Receptor Agonists

Heres a brief timeline of their development: 2005 : Approved for treating type 2 diabetes

6 It is important to note that semaglutide 2.4 mg injection has a Boxed Warning for possible thyroid tumors, including cancer, and should not be used in those with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2)

Rotating Injection Sites Changing the exact spot of injection each week is important for several reasons: It helps prevent lipohypertrophy, a condition where fat tissue builds up under the skin, potentially affecting medication absorption

Mar 10, 2026 Diabetes, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,128 views Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of type 2 diabetes and obesity